EW Stock Dips as Profit Matches Expectations, Sales Edge Ahead

Edwards Lifesciences Reports In-Line Profit and Narrow Sales Beat for Q4

Medtech giant Edwards Lifesciences (EW) announced its fourth-quarter results, reporting an in-line profit and a narrow sales beat. During the quarter, sales grew by 14% to reach $1.53 billion, exceeding analysts’ expectations of $1.5 billion. Adjusted earnings remained flat year over year at 64 cents per share, meeting expectations.